The drugmaker shed billions of dollars in value after it told investors that widening Journavx’s approval to chronic pain ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

COVID-19 variant XFG accounted for 0% of U.S. cases in May. By late-June, it became the third-most common strain.